FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2059944384> ?p ?o ?g. }

• W2059944384 endingPage "1175" @default.
• W2059944384 startingPage "1167" @default.
• W2059944384 abstract "This work provides descriptive epidemiological data of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe as defined as in the RARECARE project. We analysed 8669 incident cases registered in the period 1995–2002 by 76 population-based cancer registries (CRs), and followed up for vital status to 31st December 2003. Age-standardised incidence to the European standard population was obtained restricting the analysis to 8416 cancer cases collected by 64 not specialised CRs or with information available only for some anatomical sites. Period survival rates at 2000–2002 were estimated on 45 CRs data. Twenty-two CRs which covered the period 1988–2002 were analysed to obtain the 15-year prevalence (1st January 2003 as reference date). Complete prevalence was calculated by using the completeness index method which estimates surviving cases diagnosed prior to 1988 (‘unobserved’ prevalence). The expected number of new cases per year and of prevalent cases in Europe was then obtained multiplying the crude incidence and complete prevalence rates to the European population at 2008. We estimated 5204 new cases per year (10.5 per million) to occur in Europe, of which 48.7% were melanomas of uvea, 24.8% melanomas of mucosa and 26.5% adnexal carcinomas of the skin. Five-year relative survival was 40.6% and 68.9% for mucosal and uveal melanomas, respectively. Adnexal skin carcinomas showed a good prognosis with a survival of 87.7% 5 years after diagnosis. Northern Europe, United Kingdom (UK) and Ireland showed the highest 5-year survival rate for uveal melanomas (72.6% and 73.4%), while Southern Europe showed the lowest rate (63.7%). More than 50,000 persons with a past diagnosis of one of these rare cancers were estimated to be alive at 2008 in Europe, most of them (58.8%, n = 29,676) being patients with uveal melanoma. Due to the good prognosis and high incidence of uveal melanomas, these malignancies are highly represented among the long-term survivors of the studied rare cancer types. Therefore, maximising quality of life is particularly important in treatment of uveal melanoma. As regards mucosal melanomas, the centralisation of treatment to a select number of specialist centres as well as the establishment of expert pathology panels should be promoted. The geographical differences in incidence and survival should be further investigated analysing the centre of treatment, the stage at diagnosis and the treatment." @default.
• W2059944384 created "2016-06-24" @default.
• W2059944384 creator A5011350354 @default.
• W2059944384 creator A5013021232 @default.
• W2059944384 creator A5015954067 @default.
• W2059944384 creator A5017363293 @default.
• W2059944384 creator A5026512576 @default.
• W2059944384 creator A5033644402 @default.
• W2059944384 creator A5035515890 @default.
• W2059944384 creator A5038413562 @default.
• W2059944384 creator A5067410349 @default.
• W2059944384 creator A5070414377 @default.
• W2059944384 creator A5088191549 @default.
• W2059944384 creator A5091871456 @default.
• W2059944384 date "2012-05-01" @default.
• W2059944384 modified "2023-10-12" @default.
• W2059944384 title "Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe" @default.
• W2059944384 cites W1545177819 @default.
• W2059944384 cites W1563308669 @default.
• W2059944384 cites W1907184865 @default.
• W2059944384 cites W1966724428 @default.
• W2059944384 cites W1970051943 @default.
• W2059944384 cites W1970228301 @default.
• W2059944384 cites W1972497623 @default.
• W2059944384 cites W1978199271 @default.
• W2059944384 cites W1979253301 @default.
• W2059944384 cites W1984816352 @default.
• W2059944384 cites W1986956211 @default.
• W2059944384 cites W2008799409 @default.
• W2059944384 cites W2033668318 @default.
• W2059944384 cites W2039928142 @default.
• W2059944384 cites W2043600900 @default.
• W2059944384 cites W2046292072 @default.
• W2059944384 cites W2052305452 @default.
• W2059944384 cites W2057902218 @default.
• W2059944384 cites W2061857205 @default.
• W2059944384 cites W2082198095 @default.
• W2059944384 cites W2092568915 @default.
• W2059944384 cites W2114274255 @default.
• W2059944384 cites W2122979626 @default.
• W2059944384 cites W2123903509 @default.
• W2059944384 cites W2128289784 @default.
• W2059944384 cites W2140587889 @default.
• W2059944384 cites W2145471691 @default.
• W2059944384 cites W2147850345 @default.
• W2059944384 cites W2158860287 @default.
• W2059944384 cites W2159200389 @default.
• W2059944384 cites W4241294394 @default.
• W2059944384 cites W4242764360 @default.
• W2059944384 cites W4243642137 @default.
• W2059944384 doi "https://doi.org/10.1016/j.ejca.2011.10.004" @default.
• W2059944384 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22119735" @default.
• W2059944384 hasPublicationYear "2012" @default.
• W2059944384 type Work @default.
• W2059944384 sameAs 2059944384 @default.
• W2059944384 citedByCount "71" @default.
• W2059944384 countsByYear W20599443842012 @default.
• W2059944384 countsByYear W20599443842013 @default.
• W2059944384 countsByYear W20599443842014 @default.
• W2059944384 countsByYear W20599443842015 @default.
• W2059944384 countsByYear W20599443842016 @default.
• W2059944384 countsByYear W20599443842017 @default.
• W2059944384 countsByYear W20599443842018 @default.
• W2059944384 countsByYear W20599443842019 @default.
• W2059944384 countsByYear W20599443842020 @default.
• W2059944384 countsByYear W20599443842021 @default.
• W2059944384 countsByYear W20599443842022 @default.
• W2059944384 countsByYear W20599443842023 @default.
• W2059944384 crossrefType "journal-article" @default.
• W2059944384 hasAuthorship W2059944384A5011350354 @default.
• W2059944384 hasAuthorship W2059944384A5013021232 @default.
• W2059944384 hasAuthorship W2059944384A5015954067 @default.
• W2059944384 hasAuthorship W2059944384A5017363293 @default.
• W2059944384 hasAuthorship W2059944384A5026512576 @default.
• W2059944384 hasAuthorship W2059944384A5033644402 @default.
• W2059944384 hasAuthorship W2059944384A5035515890 @default.
• W2059944384 hasAuthorship W2059944384A5038413562 @default.
• W2059944384 hasAuthorship W2059944384A5067410349 @default.
• W2059944384 hasAuthorship W2059944384A5070414377 @default.
• W2059944384 hasAuthorship W2059944384A5088191549 @default.
• W2059944384 hasAuthorship W2059944384A5091871456 @default.
• W2059944384 hasBestOaLocation W20599443841 @default.
• W2059944384 hasConcept C107130276 @default.
• W2059944384 hasConcept C120665830 @default.
• W2059944384 hasConcept C121332964 @default.
• W2059944384 hasConcept C121608353 @default.
• W2059944384 hasConcept C126322002 @default.
• W2059944384 hasConcept C141071460 @default.
• W2059944384 hasConcept C16005928 @default.
• W2059944384 hasConcept C2776148792 @default.
• W2059944384 hasConcept C2776713392 @default.
• W2059944384 hasConcept C2777658100 @default.
• W2059944384 hasConcept C2777789703 @default.
• W2059944384 hasConcept C2778527826 @default.
• W2059944384 hasConcept C2780558122 @default.
• W2059944384 hasConcept C2908647359 @default.
• W2059944384 hasConcept C502942594 @default.
• W2059944384 hasConcept C61511704 @default.

• next